Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines
US6015564A · kind A · utility
8Cited by
0References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 10, 1999 |
| Grant date | Jan 18, 2000 |
| Priority date | — |
| Expiry date | Feb 10, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16322
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cytotoxic lymphocyte-inducing lipopeptides comprising a peptide part having between 10 and 40 amino acids approximately and comprising at least one tigenic determinant. The lipopeptides also comprise one or more chains derived from fatty acids and one or more modified steroid groups. Said lipopeptides may be used for immunizing the human or animal body against pathogenic agents such as viruses or parasites. The peptide part may, in particular, be a fragment of the protein encoded by the ENV gene, by the NEF gene or by the GAG gene of HIV viruses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.